DOT1L and neoplasm: In this study, we show that DOT1L is overexpressed in ovarian cancer and that this overexpression is linked to advanced tumor stage as patients with higher DOT1L expression exhibit shorter progression-free and overall survival (OS) than those with lower DOT1L expression.